The shares of Sage Therapeutics, Inc. (NASDAQ: SAGE) increased significantly after the firm acknowledged receiving a non-binding buyout proposal from Biogen Inc. Following the news,
On January 21, American stock exchanges traded in a narrow range. The S&P 500 index rose by a symbolic 0.03%, to 3853 points, the NASDAQ
At Stocktstelegraph.com, we are committed to helping investors make smart and profitable decisions. Our goal is to make investing easier and more accessible to everyone. We strive to provide the best and most reliable market information, news and analysis to ensure that our readers can make informed decisions.